Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 8/20 | 1.00 |
| ▸ | LMNA | P02545 | 7/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 6/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 3/20 | 1.00 |
| ▸ | OPRK1 | P41145 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | MAOA | P21397 | 1/20 | 1.00 |
| ▸ | ESR1 | P03372 | 9/20 | 0.70 |
| ▸ | SLC6A4 | P31645 | 6/20 | 0.70 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.70 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.70 |
| ▸ | ACHE | P22303 | 1/20 | 0.70 |
| ▸ | NR3C1 | P04150 | 5/20 | 0.67 |
| ▸ | ABCB11 | O95342 | 4/20 | 0.67 |
| ▸ | SHBG | P04278 | 4/20 | 0.67 |
| ▸ | TSHR | P16473 | 3/20 | 0.67 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lynestrenol SCHEMBL16180701 | 1.00 | PGR (1.00) | PGRLMNACYP3A4CYP2C19ALDH1A1 | |
| Lynestrenol SCHEMBL9699960 | 1.00 | PGR (1.00) | PGRLMNACYP3A4CYP2C19ALDH1A1 | |
| Lynestrenol SCHEMBL11575942 | 0.99 | PGR (0.98) | PGRLMNACYP3A4CYP2C19ALDH1A1 | |
| Ethinyl Estradiol SCHEMBL9102012 | 0.87 | ESR1 (0.75) | PGRLMNACYP3A4CYP2C19ALDH1A1 | |
| SCHEMBL21807745 | 0.84 | CYP2C19 (0.74) | PGRLMNACYP3A4CYP2C19ALDH1A1 | |
| Cingestol SCHEMBL12178106 | 0.84 | CYP3A4 (0.72) | PGRLMNACYP3A4CYP2C19ALDH1A1 | |
| Cingestol SCHEMBL282508 | 0.84 | CYP3A4 (0.72) | PGRLMNACYP3A4CYP2C19ALDH1A1 | |
| SCHEMBL11858237 | 0.83 | PGR (0.71) | PGRLMNACYP3A4CYP2C19ALDH1A1 | |
| SCHEMBL30140942 | 0.83 | PGR (0.71) | PGRLMNACYP3A4CYP2C19ALDH1A1 | |
| SCHEMBL11858232 | 0.83 | PGR (0.71) | PGRLMNACYP3A4CYP2C19ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5295 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250195450-A1 | BIOERODIBLE DRUG DELIVERY IMPLANTS | HERA HEALTH SOLUTIONS INC. | 2025-06-19 | — | — | US | claimed |
| US-12318395-B2 | Ethinyl estradiol-β-cyclodextrin complex and process for preparing thereof | LABORATORIOS LEON FARMA, S.A. (ES) | 2025-06-03 | — | — | US | claimed |
| EP-3884914-B1 | AN OVERMOULDABLE SUBSTRATE AND USES THEREOF | QPHARMA AB (SE) | 2025-05-21 | — | — | EP | claimed |
| US-20250152556-A1 | ETRASIMOD FOR USE IN TREATING S1P1 RECEPTOR-ASSOCIATED DISORDERS IN COMBINATION WITH HORMONE TREATMENT | ARENA PHARMACEUTICALS, INC. (US) | 2025-05-15 | — | — | US | claimed |
| US-20240269066-A1 | USE OF CYP450 INHIBITOR IN INHIBITING OR KILLING MITES AND TREATING XEROPHTHALMIA | PRECVISION BIOTECHNOLOGIES LTD. (CN) | 2024-08-15 | — | — | US | claimed |
| US-20240207369-A1 | In Vitro Drugs from Prodrugs and Use Thereof | BRANDENBURGISCHE TECHNISCHE UNIVERSITAT COTTBUS-SENFTENBERG (DE) | 2024-06-27 | — | — | US | claimed |
| US-11992431-B2 | Inserter | BAYER OY (FI) | 2024-05-28 | — | — | US | claimed |
| US-20240165130-A1 | COMPOSITE DRUG PARTICLES AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2024-05-23 | — | — | US | claimed |
| EP-4353264-A1 | USE OF CYP450 INHIBITOR IN INHIBITING OR KILLING MITES AND TREATING DRY EYE SYNDROME | Precvision Biotechnologies Ltd. (CN) | 2024-04-17 | — | — | EP | claimed |
| EP-4330382-A2 | IN VITRO DRUGS FROM PRODRUGS AND USE THEREOF | Brandenburgische Technische Universität Cottbus-Senftenberg (DE) | 2024-03-06 | — | — | EP | claimed |
| US-4639439-A | PROLACTIN-ELEVATING BENZAMIDE, PROGESTOGEN | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE DE FRANCE (FR) | 1987-01-27 | — | — | US | claimed |
| US-4540564-A | DIHYDROPYRIDINE AND/OR PYRIDINIUM SALT REDOX CARRIER | UNIVERSITY OF FLORIDA (US) | 1985-09-10 | — | — | US | claimed |
| EP-0110955-A1 | BRAIN-SPECIFIC DRUG DELIVERY. | UNIV FLORIDA (US) | 1984-06-20 | — | — | EP | claimed |
| WO-1983003968-A1 | BRAIN-SPECIFIC DRUG DELIVERY | UNIVERSITY OF FLORIDA (US) | 1983-11-24 | — | — | WO | claimed |
| US-4346709-A | Drug delivery devices comprising erodible polymer and erosion rate modifier | ALZA CORPORATION (US) | 1982-08-31 | — | — | US | claimed |
| EP-0033164-A2 | Composition for preventing and inhibiting baldness | von Kistowski, Irmgard, Dr. (DE) | 1981-08-05 | — | — | EP | claimed |
| US-4143136-A | PROGESTAGENIC COMPOUND, LUTENIZING HORMONE RELEASE FACTOR | AKZONA INCORPORATED (US) | 1979-03-06 | — | — | US | claimed |
| US-4054651-A | Method of contraception | RICHARDSON-MERRELL INC. (US) | 1977-10-18 | — | — | US | claimed |
| US-3942641-A | Dispensing packages containing novel cyclic progestogen-interrupted estrogen oral contraceptive regimens | SYNTEX CORPORATION (PM) | 1976-03-09 | — | — | US | claimed |
| US-3932635-A | Novel cyclic progestogen-interrupted estrogen oral contraceptive regimens | SYNTEX CORPORATION (PM) | 1976-01-13 | — | — | US | claimed |